首页>
外国专利>
USE OF EXTRACTS OBTAINED FROM IRIDACE AND CIMICIFUGA RACEMOSA AND TECTORIGENIN AS ORGANOSELECTIVE MEDICINE OF THE TYPE OF ESTROGENEO WITHOUT UTEROTROPIC EFFECT
USE OF EXTRACTS OBTAINED FROM IRIDACE AND CIMICIFUGA RACEMOSA AND TECTORIGENIN AS ORGANOSELECTIVE MEDICINE OF THE TYPE OF ESTROGENEO WITHOUT UTEROTROPIC EFFECT
展开▼
机译:从鸢尾,小MIC子和番茄红素中提取的提取物作为雌激素型无激素疗法的有机选择药物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to the utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament for selectively treating and/or for the prophylaxis of cardiovascular diseases, especially arteriolosclerosis, osteoporosis and climacteric symptoms, for example, for preventing or alleviating hot flashes. Virtually no uterotropic effects are observed when using said abstracts.
展开▼